Phyto Assay Presentation   Pitchfest
Upcoming SlideShare
Loading in...5
×
 

Phyto Assay Presentation Pitchfest

on

  • 666 views

 

Statistics

Views

Total Views
666
Views on SlideShare
655
Embed Views
11

Actions

Likes
0
Downloads
0
Comments
0

2 Embeds 11

http://www.linkedin.com 10
https://www.linkedin.com 1

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Phyto Assay Presentation Pitchfest Presentation Transcript

  • 1. PHYTOASSAY
    Plant-based technology for toxicity screening in drug discovery
    3R Laboratories, LLC. All Rights Reserved.
  • 2. 2
    3R LABORATORIES’ MISSION STATEMENT
    Our mission is to improve drug safety and reduce animal experiments by using plant models in predictive toxicology.
    The company is named after The Principle of 3Rs:
    Reduce, Refine and Replace animal experiments with suitable alternatives.
    (Russell and Burch, 1959)
  • 3. 3
    THE PROBLEM
    There is a high demand for reliable toxicity screening in pharmaceutical industry
    The cost of developing a successful drug is $1.4 billion; 72% of this cost is wasted on failures. Improving the prediction of failures before clinical trials by only 10% could save $100 million in development costs per drug
    Safety-related drug withdrawals:
    Merck lost 11% of its revenue ($2.5B) when it pulled Vioxx off the market in 2003; additionally, Merck funded $4.5B in settlement payouts
    Pfizer's Celebrex sales dropped 48% ($1.5B) in 2004 due to safety concerns
  • 4. 4
    THE PROBLEM
    Animal experiments – costly, lengthy, and unethical
    Cell culture-based methods – failed to meet the industry expectations, poor reproducibility
    "Previously, in vivo evaluations of toxicity were used sparingly in discovery. Now, we perform early in vivo studies on every compound being advanced into development, because catching liabilities earlier is extremely important. " Bruce Car, PhD, Bristol-Myers Squibb
  • 5. 5
    STRATEGIC OPPORTUNITY
    Plant Respiration Test
    Highly Reproducible and Sensitive
    The only test that can rank compounds according to toxicity
    "The definitive answer is really at the end of the clinical trials. What we want to do early on is to proceed to a rank-ordering exercise and select the candidates with an optimal toxicology profile to move into a preclinical safety study." Eric Blomme, PhD, Abbott Laboratories
    Ethical
    The US Animal Welfare Act requires manufacturers and researches to explore all possible alternatives before resorting to animal testing.
  • 6. 6
    STRATEGIC OPPORTUNITY
    Plant Respiration Test
    Preliminary results show better correlation with animal models than cell cultures
    Regardless of the mechanism of action, toxic substances affect cellular structures of an organism and disrupt normal cellular processes
    Cellular respiration is used as a measure of the disruption in cellular metabolism
  • 7. 7
    MARKET SIZE
    US market for toxicology in vitro, 2007 (early phase drug discovery only)
    $1.1 billion, AAGR 15%
  • 8. 8
    QUESTIONS?
    information@3RLaboratories.com